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ABSTRACT
We have obtained new crystal structures of Mycobacterium tuberculosis topoisomerase I, including structures with ssDNA substrate bound to the active site,
with and without Mg2+ ion present. Significant enzyme conformational changes upon DNA binding
place the catalytic tyrosine in a pre-transition state
position for cleavage of a specific phosphodiester
linkage. Meanwhile, the enzyme/DNA complex with
bound Mg2+ ion may represent the post-transition
state for religation in the enzyme’s multiple-step DNA
relaxation catalytic cycle. The first observation of
Mg2+ ion coordinated with the TOPRIM residues and
DNA phosphate in a type IA topoisomerase active
site allows assignment of likely catalytic role for
the metal and draws a comparison to the proposed
mechanism for type IIA topoisomerases. The critical function of a strictly conserved glutamic acid in
the DNA cleavage step was assessed through sitedirected mutagenesis. The functions assigned to the
observed Mg2+ ion can account for the metal requirement for DNA rejoining but not DNA cleavage by type
IA topoisomerases. This work provides new structural insights into a more stringent requirement for
DNA rejoining versus cleavage in the catalytic cycle
of this essential enzyme, and further establishes the
potential for selective interference of DNA rejoining
by this validated TB drug target.
INTRODUCTION
Mycobacterium tuberculosis is the chief causative agent of
tuberculosis (TB), the leading cause of morbidity and mor-

tality globally with an estimated 10.4 million cases and 1.8
million deaths annually as reported by WHO in 2017. M. tuberculosis topoisomerase I (MtbTOP1) is a validated target
for much needed new antibiotics that can be used against
the MDR-TB (multidrug-resistant tuberculosis) cases that
are difficult to treat (1–3). Topoisomerases control the topological state of the genome, thus affecting vital cellular
processes including replication, transcription, recombination and repair (4–6). Type I topoisomerases catalyze DNA
topological transformations by breaking and rejoining a
single strand of DNA at a time, and are divided into type
IA, type IB and type IC subfamilies based on distinctively different protein sequences and catalytic mechanisms
(4,5,7,8). MtbTOP1 and topoisomerase I present in all bacterial pathogens are type IA topoisomerases that are needed
for resolving topological barriers that require the passage of
DNA through the break created on single-stranded DNA
(ssDNA) (6,9). This can be exploited for bactericidal action
with topoisomerase poison inhibitors (10–12) that can stabilize the break by inhibiting DNA rejoining. The bacterial
type IIA topoisomerases have been targeted extensively for
discovery of antibiotics that include the widely used fluoroquinolones (13,14). The efforts to discover bacterial topoisomerase I inhibitors would be aided greatly by the knowledge of how DNA religation following formation of the covalent intermediate can be inhibited.
Type IA topoisomerases share certain functional and
structural elements of similarities with type IIA topoisomerases (15), even though these two classes of topoisomerases appear to have evolved independently as essential
topoisomerase activities in living organisms (9). Both type
IA and type IIA topoisomerases form a 5 -phosphoryl tyrosine linkage with cleaved DNA in a covalent intermediate
(16), and divalent metal ions are absolutely required for the
change in topology catalyzed by these topoisomerases (7).
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However, there is a significant difference in the biochemical mechanism of these two classes of topoisomerases. Type
IA topoisomerases can cleave DNA in the absence of divalent metal ions to form a covalent intermediate (17), while
DNA cleavage by type IIA topoisomerases requires the addition of divalent metal ions (18). The requirement of metal
ions for DNA religation, but not for DNA cleavage by bacterial topoisomerase I may present an opportunity for selective inhibition of DNA religation by small molecule inhibitors. None of the previously determined structures of
type IA topoisomerases has divalent metal ions and DNA
both present at the active site. The role of metal ions in the
catalytic mechanism of bacterial topoisomerase I needs to
be clarified further by structural information.
Here, we present new structures of MtbTopI determined
by X-ray crystallography. For the first time, divalent metal
ion can be observed to coordinate DNA, water molecules,
and the acidic functional groups in the active site of a type
IA topoisomerase. We observed metal ion interactions with
the aspartates in the DxD motif (D111 and D113), proposed previously based on genetic and biochemical data
(19–21). The invariant glutamic acid (E24) in the TOPRIM
domain is in a position for key roles in the catalysis of DNA
cleavage-religation. The requirement of the carboxyl group
on E24 for acid-base catalysis of DNA cleavage in the absence of divalent metal ions is further clarified by study of
the E24A and E24Q mutants. Based on the new structural
results, we compare the active sites of topoisomerase IA,
IIA and III; and draw their possible similarities and differences in their catalytic mechanisms, particularly between
topoisomerase IA and IIA in the role of the metal ions
(18,22,23).
MATERIALS AND METHODS

of the crystals for X-ray diffraction experiments, they were
harvested and transferred to cryoprotectant solution that
contains 25% glycerol in addition to crystallization buffer
for a few minutes and then cryocooled directly in liquid nitrogen.

Data collection and structure determination
Single-wavelength diffraction data were collected at 100 K
from cryocooled crystals. All data were obtained at the 19ID beamline of the Structural Biology Center at the Advanced Photon Source at Argonne National Laboratory using the program SBCcollect (25). The intensities of each
data set were integrated, scaled, and merged with the HKL3000 program suite (26). All structures were determined using the molecular replacement method (27). The apo form
structure of MtbTOP1-704t (PDB code: 5D5H (24)) was
used as the first search template. For the first structure
of MtbTOP1-704t/ssDNA complex, the covalent complex
of EcTOP1 (E. coli topoisomerase I) with ssDNA (PDB
code: 3PX7 (28)) turned out to be the best search template.
The subsequently refined MtbTOP1-704t/ssDNA structure (PDB code: 6CQI, Table 1) has in turn served as the
template for the structural determination of MtbTOP1704t/ssDNA/Mg complexes. After structural determination, the model rebuilding was performed using the program Coot (29) based on Fourier maps. After several alternative cycles of model building and refinement, the final
models were refined using the program phenix.refine (30)
(Table 1). There are a few density breaks within the archlike D2 domain of each structure, particularly in MtbTOP1704t/ssDNA.

Protein expression and purification
Full length (residues 2-934) wild-type and mutant
MtbTOP1 enzymes, as well as MtbTOP1-704t (residues
2–704), were expressed in the Escherichia coli T7 Express
Crystal strain (New England BioLabs) at 22◦ C following
induction with 1 mM IPTG as described (24). The proteins
with His6 -Mocr fusion tag were purified by affinity chromatography using the Ni Sepharose 6 Fast Flow resin (GE
Healthcare). For crystallography studies, MtbTOP1-704t
was further purified by ssDNA cellulose and gel filtration
chromatography following the removal of the fusion tag by
TEV protease digestion (24).
Crystallization
The purified MtbTOP1-704t (77.5 kDa) was concentrated
to ∼90 mg/ml (∼1 mM) for crystallization. For the cocrystallization trials with ssDNA, the protein was first
mixed with an oligonucleotide in a 1:1 molar ratio and then
incubated on ice, typically for 2–3 h before crystallization
set-up. To facilitate observation of Mg2+ binding in crystal
structures, before incubation additional MgCl2 stock solution was added to the protein/oligonucleotide mixture in
some co-crystallization trials at a final concentration of 2
mM. The crystallization screening and conditions for obtaining the crystals are described in SI. For the preparation

Enzyme activity assays
The relaxation activity was assayed using supercoiled
pBAD/Thio plasmid DNA substrate as described (31). For
assay of DNA binding, increasing amounts of wild-type or
mutant MtbTOP1 were incubated with 5 pmol of oligonucleotide STS32 (21) labeled with 32 P on the 5 -end in 10
l of 20 mM Tris–HCl pH 8.0,100 g/ml BSA, 18% glycerol, 0.5 mM EDTA at 37◦ C for 5 min. The reactions were
then placed on ice for 5 min before separation of the noncovalent protein–DNA complex and free substrate by electrophoresis in 8% polyacrylamide gel with 0.5X TBE (45
mM Tris-borate pH 8.3, 1 mM EDTA) buffer at 6 V/cm
for 4.5 h. The dried gel was analyzed by PhosphorImager.
For assay of DNA cleavage activity, the labeled oligonucleotide (0.5 pmol) was incubated with indicated amount
of enzyme in 5 l of 10 mM Tris–HCl (pH 8.0) buffer at
37◦ C for 30 min. The reactions were terminated by the addition of an equal volume of stop solution (79% formamide, 2
mM NaOH, 0.1 mM EDTA, 0.04% bromophenol blue). After heating at 95◦ C for 5 min, the oligonucleotide substrates
and cleavage products were separated by electrophoresis in
a sequencing gel (15% gel for substrate STS32, 20% gel for
other oligonucleotide substrates) followed by PhosphorImager analysis.
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Table 1. Data collection and refinement statistics
Data collection
Space group
Unit Cell dimensions
a, b,c (Å)
α, β, γ (◦ )
Protein MW Da (residue)
DNA MW Da (residue)
Mol or complex (AU)
Wavelength (Å)
Resolution (Å)
Number of unique reflections
Completeness (%)
Redundancy
Rmerge
I/(I)
CC1/2
Wilson B-factors (Å2 )
Phasingf
refinement
Resolution
No. reflections (work/test)
Rwork /Rfree
No.of atoms
Protein/DNA
Water/others
B-factors (Å2 )
Protein/DNA
Water/Others
R.m.s deviation
Bond length (Å)
Bond angle (◦ )
Ramachandran Plot (%) (57)
Residues in most favored regions,
in additional allowed regions,
in generously allowed regions,
in disallowed region
PDB code
a Not

MtbTOP1704t/MTS2–11
P21

MtbTOP1704t/MTS2-13/Mg
P21

MtbTOP1-704t (high
resolution)
P21 21 21

MtbTOP1-704t
(second crystal form)
C2

68.78, 44.98, 129.2
90, 90.60, 90
77468.3 (703)a
3362.2 (11)
1
0.9792
47.0–2.42
29799
97.1 (82.4)b
4.0 (3.2)b
0.087 (0.641)b
19.5 (1.2)b
0.82b
55.9

67.63, 44.68, 128.87
90, 90.61, 90
77468.3 (703)a
3970.6 (13)
1
0.9792
37.5–3.00
15372
97.4 (93.3)c
4.6 (2.9)c
0.132 (0.816)c
9.2 (1.1)c
0.50c
63.1

63.78, 93.59, 140.6
90, 90, 90
77468.3 (703)a
NA
1
0.9792
47.2–2.15
46076
99.5 (99.0)d
5.4 (4.8)d
0.094 (0.800)d
17.4 (1.9)d
0.73d
35.2

170.6, 64.42, 169.4
90, 112.2, 90
77468.3 (703)a
NA
2
0.9793
42.3–2.75
45105
97.7 (95.7)e
5.9 (5.7)e
0.141 (0.843)e
14.3 (1.7)e
0.52e
50.9

47.0–2.42
28222/1484
0.218/0.272

37.5–3.00
14613/735
0.189/0.249

47.2–2.15
43697/2310
0.168/0.211

42.3–2.75
42851/2210
0.198/0.243

5032/202
18/24

5289/202
14/9

5322/NA
303/5

10579/NA
47/0

95.0/94.5
69.6/105.2

74.4/79.8
41.1/83.8

53.1/NA
46.8/115.6

64.0/NA
40.6/NA

0.008
1.083

0.002
0.418

0.007
0.804

0.003
0.501

89.9
10.1
0.0
0.0
6CQI

87.1
12.4
0.2
0.3
6CQ2

91.8
8.2
0.0
0.0
5UJ1

91.4
8.4
0.0
0.3
5UJY

including three N-terminal vector-derived residues, SNA.

b (Last resolution bin, 2.42–2.46 Å).
c (Last resolution bin, 3.00–3.07 Å).
d (Last resolution bin, 2.15–2.18 Å).
e (Last resolution bin, 2.75–2.80 Å).
e Molecular replacement.

RESULTS
New co-crystals of MtbTOP1-704t with short ssDNA substrates
Co-crystallization trials of MtbTOPI-704t (24) were set
up with MTS (Mycobacterial Topoisomerase Substrate)
oligonucleotides of various lengths with sequences derived
from a 32 base long substrate previously identified as having a strong topoisomerase site (STS) (21). Multiple crystal forms were harvested and their X-ray diffraction data
were collected. The highest resolution data set (2.42 Å) was
obtained from a co-crystal with a short, 11-mer oligonucleotide (MTS2–11, 5 -TTCCGCTTGAC-3 ). This crystal
structure (MtbTOP1-704t/MTS2–11, PDB ID: 6CQI, Table 1) represents a topoisomerase I/ssDNA complex in the
absence of metal ions at the active site, Figure 1.
Conformational change of MtbTOP1-704t upon ssDNA
binding
The MtbTOP1-704t construct includes four N-terminal domains (D1–D4) and one C-terminal domain (D5). D1–D4
form a toroidal assembly found in all topoisomerase IA
while D5 represents the Topo C Rpt subgroup of bacterial

topoisomerase C-terminal repeats (Figure 1 and SI movies
1 and 2) (24). The binding of oligonucleotide MTS2–11
causes a significant conformational change relative to the
apo MtbTOP1-704t structure (PDB ID:5D5H), particularly to its N-terminal toroidal assembly. An overall superposition (32) of the holo form structure onto its apo form results in an rmsd (root-mean-square deviation) value of 2.34
Å. The rmsd values from the pairwise alignments of individual domains are 0.94, 0.84, 0.75, 1.86 and 0.63 Å for D1,
D2, D3, D4 and D5, respectively.
While D3 contains the catalytic Y342, it exhibits the least
conformational change among N-terminal domains upon
ssDNA binding. To appreciate the relative domain-domain
movements within the toroidal assembly, only the D3 domains from the apo and the holo MtbTOP1-704t structures
are used for an alignment calculation. The primary interdomain re-arrangement can be approximated as a shift of
∼8 Å by D1 with respect to D3 (Figure 1 and SI movie 1
and 2). This movement of D1 from D3, extending the DNA
binding groove within D4 to the space between D1 and D3,
provides ssDNA access to the active site. D4 itself has the
largest conformational change, mostly due to a complete
opening of its DNA binding groove by intra-domain helix
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Figure 1. A stereoview of a ribbon diagram of the structure of MtbTOP1-704t/ssDNA complex. The five individual domains, D1–D5, are colored in cyan,
pink, blue, yellow and green, respectively. The phosphate backbone of the oligonucleotide substrate is in orange with its polarity labeled. The catalytic
residue Y342 is drawn in stick format to highlight its active site position. Y176 is drawn to indicate the relative position between Y342 and the C nucleotide
binding pocket (Figure 2B) four bases upstream of scissile phosphate. Only a few secondary structures are labeled for the purpose of discussion. The
numberings of these secondary structures are based on individual domains. The conformational changes induced by ssDNA binding can be viewed in SI
movies 1 and 2. The program Pymol was used for the preparation of Figures 1–4.

re-arrangement including rotations, primarily involving ␣2,
␣7 and ␣8 helices (Figure 1 and SI movie 1 and 2). Accompanying the intra-domain rotation within D4 and the interdomain shift of D1 to D3, the associations of D3 to D1 and
D4 are greatly reduced. The interface area between D3 and
D1 decreases from 690 to 240 Å2 while the interface area
between D3 and D4 is reduced from 760 to 510 Å2 . The
ssDNA binding thus contributes to the creation of a gate
between D3 and D1 plus D4, which has been proposed to
be a critical step for the entry of the T-strand into the interior hole of the toroid in the catalytic mechanism of type IA
topoisomerase (33–35).
In addition to the first apo MtbTOP1-704t structure reported earlier (24), more apo MtbTOP1-704t structures
(e.g. PDB ID:5UJ1 and 5UJY, Table 1) have been determined from crystals grown under different conditions.
No significant conformational change has been observed
among these structures even though they have different
crystal symmetries. This indicates that the N-terminal
toroidal assembly of the enzyme is quite stable by itself.
The conformational change induced by ssDNA binding in
the structure of MtbTOP1-704t/MTS2–11 is comparable to
that observed in the EcTOP1 covalent complex (28). The
rmsd value from an overall alignment of the two structures
is only 1.69 Å, significantly less than the rmsd value from
the superposition of the apo to holo form of MtbTOP1-704t
as described above. Since ssDNA is intact in the complex
structure (Figure 2A), this suggests that this MtbTOP1704t/MTS2–11 structure may correspond to a pre-catalytic
state poised for DNA cleavage in the absence of Mg2+ ion as
elaborated later. This structure may also resemble the postligation state.

Conformation of ssDNA substrate and its kink
The ssDNA MTS2–11 is intact in the structure (Figure 2A).
Its sugar phosphate backbone is mostly buried along the
bottom of the DNA-binding groove from D4 to the edge of
the D1-D3 interface in a 5 to 3 direction (Figure 1). The
bases of the seven nucleotides from positions –4 to +3 resemble the stacking conformation of one B-DNA strand
as described earlier for DNA bound to E. coli topoisomerase III (EcTOP3) (36) and topoisomerase I (EcTOP1)
(37). This conformation is interrupted between the –4 and
–5 positions with a backbone kink and insertion of a tyrosine side chain from the enzyme (Y176) between the two
bases (Figure 2B). The kink contributes to the recognition
of cytosine at the –4 position relative to the scissile phosphate for all preferred bacterial topoisomerase I cleavage
sites (28,31,38). Aside from the interactions with the –4 cytosine base involving R168, R172 and Y176, there are additional enzyme–ssDNA interactions, including a series of
arginine–phosphate salt bridges mediated by R194, R344
and R547 (Figures 2B and 3). The specific interaction with
the cytosine base at the –4 position as seen in the EcTOP1
covalent complex structure also provided additional support for assigning this structure as corresponding to the pretransition state in the reaction pathway that would lead to
the formation of the covalent complex.
Active-site conformation in the absence of Mg2+ binding
The conformational change upon ssDNA binding not only
helps to create the gate for the passing of the T-strand, it
also brings catalytic residues together to form an active site.
The active site configuration of MtbTOP1-704t/MTS2–11,
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Figure 2. Conformation of ssDNA substrate and its interaction with
MtTOP1-704t. (A) The ssDNA bound to MtbTOP1-704t resembles a BDNA conformation, which is interrupted between –4 and –5 positions. The
2Fo-Fc electron density map is drawn in gray mesh and contoured at 1
level and within 2.1 Å of the ssDNA, which is drawn in stick format. (B)
Interaction between ssDNA and MtbTOP1-704t including the creation of
a ssDNA kink and the C nucleotide binding pocket at –4 position. Several arginine residues involved in the interaction with either the phosphate
backbone (R194 and R547) or bases (R167, R168 and R172) are presented.
One anchoring site of ssDNA to MtTOP1-704t is located at the phosphate
group between –3 and –4 positions. The phosphate group is positioned below the N-terminus of the ␣3 helix of D4, which has an equivalent charge
of about +0.5 unit. In the apo structures of MtbTOP1-704t, a phosphate
group or a sulfide group from crystallization buffer is commonly found at
this position. The tyrosine Y176 inserts between the bases at –4 and –5 positions, helping create a kink in the base packing of ssDNA. The residue
Y176 forms – stacking with bases at both –4 and –5 positions. R168
and R172 provide specific interactions to the C nucleotide at –4 position.
Both Figure 2A and B were prepared based on the MtTOP1-704t/MTS2–
11 structure (PDB code: 6CQI, Table 1).

in the absence of Mg2+ ion, is similar to that of the covalent complex of EcTOP1/ssDNA(28) and EcTOP3/ssDNA
(36) complexes, but with new features (Figure 3A). The catalytic tyrosine Y342 makes two hydrogen bonds from the
top to the scissile phosphate, including one to its bridging
5 -oxygen atom and one to a non-bridging O atom (Figure
3A). The distance between the hydroxyl group of Y342 to
the phosphorous of the scissile phosphate is 2.90 Å. The
scissile phosphate is being positioned on one side by R344
through an arginine-phosphate salt bridge, and on the other

Figure 3. Active sites in the absence and in the presence of Mg2+ ion. (A)
The active site interaction pattern between MtTOP1-704t and ssDNA in
the absence of Mg2+ ion. The key residues from MtbTOP1-704t and ssDNA are drawn in stick format. All hydrogen bonds and salt bridges are
drawn in magenta dash lines with some bond distances labeled. The distance between the phenolic oxygen of Y342 to the scissile phosphorus atom
is 2.90 Å. The residue K28, as discussed in text, is too far away from the
scissile phosphate. The 2Fo – Fc electron density map is drawn in grey
mesh and contoured at 1 level and within 2.1 Å of the ssDNA and the
residues of E24, D111, D113 and Y342. (B) The active site interaction pattern between MtbTOP1-704t and ssDNA in the presence of Mg2+ ion. The
MtbTOP1-704t complex shown in this figure is slightly rotated along the
horizontal axis with respect to that shown in A for better view of the Mg2+
ion binding site. In addition to hydrogen bonds and salt bridges, all Mg–
O bonds are also drawn in magenta dash lines. The distance between the
phenolic oxygen of Y342 to the scissile phosphorus atom is 3.13 Å. The
2Fo – Fc electron density map is drawn in grey mesh and contoured at 1
level and within 2.1 Å of the ssDNA, the residues of E24, D111, D113 and
Y342, the metal ion, and water molecules. The insert figure displays simulated annealing omit maps of the metal-binding site, 2Fo – Fc map in grey
at contour level of 1, and Fo – Fc map in pink at contour level of 5. The
simulated annealing refinement with a starting temperature of 5000 K was
performed after omitting Mg2+ and W1. Figure A was prepared based on
the MtTOP1-704t/MTS2–11 structure (PDB code: 6CQI, Table 1). Figure B was prepared based on the MtTOP1-704t/MTS2-13/Mg structure
(PDB code: 6CQ2, Table 1).
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side by E24 through a hydrogen bond from its bridging 3 oxygen atom (Figure 3A). E24 also forms a hydrogen bond
with the amide group of D111, bridging the catalytic residue
to the scissile phosphate.
The MtbTOP1-704t/MTS2–11 structure does not have
a positively-charged lysine side chain interacting with the
DNA at the active site. In contrast, lysine K8 in the
EcTOP3/ssDNA complex interacts with the putative scissile phosphate. The positively charged K8 was believed to
help stabilize the negative charge on non-bridging oxygens of the pentavalent transition state (36). However, in
MtbTOP1 as well as in EcTOP1, this lysine residue is not
conserved, being replaced by a serine in the bacterial topoisomerase I sequence (39). A nearby lysine K28 in MtbTOP1
(equivalent to K13 in EcTOP1) is >6.8 Å away from the
scissile phosphate based on measurement of the distances
between the K28 N atom to the oxygen atoms of the
phosphate (Figure 3A). The absence of an EcTOP3 K8
equivalent in MtbTOP1 and EcTOP1 active site structures
(Supplementary Figure S1) implies some difference between
the catalytic mechanisms of bacterial topoisomerase I and
topoisomerase III, as suggested earlier (28,40). The side
chain of D111 is quite mobile and without well-defined electron density. D111 can potentially make a hydrogen bond
with an invariant H389 on the long loop between ␣3 and
␣4 helices of D3. H389 also can potentially form a -
stacking with Y342 in this MtbTOP1-704t/MTS2–11 complex. It is noted that the ␣3 ␣4 loop of D3 is very flexible, allowing the position and conformation of the strictlyconserved histidine to be highly variable from structure to
structure. Similar observations have been made for the covalent EcTOP1 complex (28) as well as in the open and the
mutant forms of EcTOP3, in which the histidine forms a
nearly parallel displaced - stacking with the catalytic tyrosine (36,41). However, in the closed and the intermediate
forms of EcTOP3, there is no interaction between these two
residues. The flexible ␣3 ␣4 loop of D3 and its conserved
histidine could play a potential role in charge relay for DNA
cleavage and religation (28,42). The direct - interaction
with the catalytic tyrosine may also allow the invariant histidine to assist in stabilization of the transition state for DNA
cleavage in the absence of Mg2+ .
Structure of active site with bound Mg2+ ion
Mg2+ plays an essential role in DNA religation by type
IA topoisomerase (17,21,43). However, divalent metal ions
have never been observed in any co-crystal structures of the
topoisomerase IA-DNA complex. After extensive screening of MtbTOP1-704t/ssDNA crystals grown under different conditions, one crystal structure of MtbTOP1-704t
in complex with a 13-mer oligonucleotide, MTS2-13 (PDB
ID:6CQ2, Table 1) reveals the first metal-binding mode at
the enzyme active site (Figure 3B). Compared to the structure of MtbTOP1-704t/ssDNA in the absence of metal ion
(Figure 3A), the extra electron densities in an approximately
globular shape between the scissile phosphate and the carboxyl groups of E24 and D111 strongly indicate a site of
bound Mg2+ ion (Figure 3B). One water molecule, W1, was
assigned to coordinate the metal ion, forming a distorted
octahedral geometry with one ligand missing. It should be

mentioned that the position of the side chain of D111 is not
well-defined in electron density maps, suggesting that this
residue can adopt multiple positions, with one of the positions engaged in metal binding. After applying Mg-O bond
distance restraints (2.10 ± 0.20 Å) to the metal-binding site
in subsequent structural refinements, the distorted octahedral geometry is stable and the model fits the electron densities well. Interestingly, the water W1 can form a hydrogen
bond with another TOPRIM acidic residue, D113 (Figure
3B), proposed previously (19,21) to interact with Mg2+ .
After obtaining this MtbTOP1-704t/MTS2-13/Mg
structure, a second structure with a metal ion bound at the
same site was determined after screening of crystals formed
in different conditions, particularly in conditions with
added MgCl2 in the crystallization buffers (see experimental details in SI Methods). In the co-crystal, harvested from
a condition with added MgCl2 , there are two MtbTOP1704t/ssDNA/Mg complexes in one asymmetric unit. Both
complexes show the aforementioned Mg2+ binding site, but
with partial occupancies of the metal ion (data not shown).
The addition of Mg2+ in the crystallization buffer did not
simply increase Mg2+ binding, at least under the buffer
condition used (SI Methods).
To evaluate any conformational change possibly induced
by Mg2+ binding, two structures, MtbTOP1-704t/MTS2–
11 and MtbTOP1-704t/MTS2-13/Mg were superimposed.
The resulted small rmsd value of 0.69 Å from the alignment
indicates no overall structural impact upon Mg2+ binding.
A close examination of their active sites also found no major changes aside from the side chain of R344, which moved
away >0.6 Å from Y342 and the scissile phosphate. Considering that the ssDNA is intact and that the distance
between Y342 hydroxyl and the phosphorous of the scissile phosphate is 3.13 Å, we propose that this MtbTOP1704t/MTS2-13/Mg structure may represent an enzymessDNA complex following DNA religation in the presence
of Mg2+ , as further elaborated later. The presence of Mg2+
would shift the cleavage-religation equilibrium from DNA
cleavage toward DNA religation (43).
Comparison of metal-binding sites between type IA and IIA
topoisomerase complexed with DNA
The first observation of Mg2+ binding at the active site of
topoisomerase IA as described above supports the proposed
roles of the TOPRIM acidic residues in metal binding (19).
We have compared the observed metal binding at active sites
in type IA topoisomerases to those revealed in type IIA
topoisomerases and in human topoisomerase III (Figure 4).
Among the type IIA topoisomerases that have been more
extensively studied, one metal-binding site and two metalbinding sites have variously been reported between different
structures. Two different catalytic mechanisms have been
proposed to account for the different observations: (a) a
mechanism with a single catalytic metal, and a second noncatalytic metal that are simultaneously occupied; and (b)
a moving metal mechanism involving only one metal ion.
The type IIA topoisomerase from S. aureus in complex with
DNA, an inhibitor, and Mn2+ ion is of the highest structural resolution (2.1 Å) among all known type IIA topoisomerase structures in complex with DNA (44). The metal-
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Figure 4. Comparison of metal-binding sites of type IA and IIA topoisomerases. (A) Ribbon diagram of Mg2+ binding site of MtTOP1-704t/MTS213/Mg (PDB code: 6CQ2). (B) Ribbon diagram of the Mn2+ binding site of S. aureus type IIA topoisomerase complex with inhibitor and DNA (PDB
code: 2XCS). Residues are labeled based on the numberings in PDB file. Waters are renumbered for convenience. (C) Ribbon diagram of the S. cerevisiae
type IIA topoisomerase covalent complex with two Zn2+ binding sites (PDB code: 3L4K). Residues are labeled based on the numberings in PDB file. (D)
Ribbon diagram of the active site of human topoisomerase III␣ (PDB code: 5GVC). Residues are labeled based on the numberings in PDB file. Waters are
renumbered for convenience.

binding site, including all coordinated water molecules, is
well-defined in electron density maps. The architectures of
the metal-binding sites of type IA (Figure 4A) and type
IIA (Figure 4B) topoisomerases are nearly parallel, excepting a few details of water coordination. In the MtbTOP1704t/MTS2-13/Mg structure described above, the water
W1 (Figure 4A) was largely from an assignment based on
metal coordination geometry due to the structural resolution limit. Two Zn2+ metal ions can be observed in the structure obtained for S. cerevisiae topoisomerase II (23). The
catalytic metal M(A) in this structure (Figure 4C) is believed
to participate directly in transition state stabilization and in
promoting the leaving and attacking of the O3 of the scis-

sile phosphate during DNA cleavage and religation, while
the metal M(B) is proposed to anchor the DNA (18,22,23).
Though certain details between the proposed mechanisms
for type IA and type IIA topoisomerases differ, their overall similarity lends support to a long-time proposal that type
IA and type IIA topoisomerases may have similar catalytic
mechanisms, at least for DNA religation (15).
Comparison of metal-binding sites in type IA topoisomerases
in presence/absence of DNA
Metal binding has never been observed in prior bacterial type IA topoisomerase structures. During the study of
MtbTOP1-704t, when crystals from many different condi-
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tions were screened, no metal binding had been observed
in any apo form structures, even as we gradually improved
the resolution limit from earlier-reported 2.52 to 2.15 Å
(Table 1). Human topoisomerase III␣ is the first type IA
structure (45) to show a metal-binding site in the absence of
bound DNA (Figure 4D). Structural alignments of the human topoisomerase III␣ to apo MtbTOP1-704t (PDB code:
5UJ1, Table 1) and MtbTOP1-704t/MTS2-13/Mg (PDB
code: 6CQ2, Table 1) yield rmsd values of 2.39 and 2.75
Å, respectively. It indicates that the metal-bound topoisomerase III is closer to the apo form of MtbTOP1-704t than
to its holo form. This is likely due to the absence of bound
DNA in the human topoisomerase III␣ structure.
An examination of the metal-binding site of the human topoisomerase III␣ and a comparison to the DNAdependent metal-binding site in MtbTOP1 (Figure 4) provide the following information. (i) The highly conserved
glutamic acid (E24 in Figure 4A, E9 in Figure 4D) from
D1 (TOPRIM domain) directly interacts with metal ion in
the presence/absence of DNA. (ii) The two TOPRIM aspartate residues (D111 and D113 in Figure 4A, D117 and
D119 in Figure 4D) can interact either directly or indirectly
through water bridge(s) with the metal ion. The side chains
of these two acidic residues appear to be relatively flexible, implying their potential for multiple conformations.
(iii) The metal-binding site mediated by the acidic residues
mentioned above needs to be stabilized by the presence of
a bound DNA (Figure 4A and B). This requirement indicates that the metal-bound topoisomerase III structure may
represent an intermediate state between an apo and a holo
(DNA-binding) state. We believe that a similar intermediate state between apo and holo can also exist in MtbTOP1,
which has not yet been selectively crystallized.

Mapping of exact cleavage site on single-stranded oligonucleotide substrates
In each of the crystal structures of the MtbTOP1/DNA
complex reported here, there is a DNA phosphate positioned at a distance (∼3.0 Å) from catalytic Y342. In order to verify that the phosphate is indeed the scissile phosphate for the cleavage of bound oligonucleotides (MTS2–11
or MTS2-13), we performed PAGE analysis of the cleavage product, using shorter 5 -end labeled oligonucleotides
for comparison (Figure 5A and B). These experimental results are consistent with the structural observations. We also
confirmed that both MtbTOP1 and M. smegmatis topoisomerase I (MsmTOP1) cleave at the same site in oligonucleotide STS32, a 32-base long ssDNA oligonucleotide
from which the sequences of the shorter oligonucleotide
substrates were derived (Figure 5C). This cleavage position
is shifted by one nucleotide toward the 5 -end from the position expected based on the previous report (21). This could
be due to differences in enzyme preparation, cleavage reaction conditions, or cleavage site mapping protocols (46).
Additionally, the identification of the scissile phosphate further confirms the recognition of a cytosine at the –4 position relative to the scissile phosphate, as discussed earlier
(28,31,38).

Requirement of the strictly conserved Glu24 for DNA cleavage
The glutamate E24 and the two aspartates present as DxD
(D111 and D113) are strictly conserved acidic residues that
have been found to be critical in the catalysis of type IA
and IIA topoisomerases, as well as other nucleotidyl transfer enzymes that require Mg2+ for their activities (19). Their
contribution to the active site as described above supports
their roles in the catalytic activities of these topoisomerases.
Despite the weak electron densities for the side chains of
D111 and D113 in the current structural models, the roles
of these two catalytic residues in Mg2+ coordination in the
active site observed here are entirely consistent with previous mutational analysis of the corresponding residues in E.
coli and M. smegmatis topoisomerase I (20,21,47). We have
attempted to construct a D111N mutant MtbTOP1 clone,
but only clones with additional mutations in the coding sequence could be isolated in E. coli, likely due to the lethality
associated with inhibition of DNA rejoining.
The residue E24 in MtbTOP1 and the residue E9 in EcTOP1 are equivalent in both sequence and structure. Sitedirected mutagenesis of EcTOP1 has shown that alanine
substitution at E9 abolishes DNA relaxation activity, and
the E9A mutant could not cleave DNA (48,49). A role for
this conserved glutamate in acid-base catalysis of DNA
cleavage and rejoining has been proposed, with the glutamate side chain providing the proton for the 3 -OH leaving
group during DNA cleavage (42), and enhancing the nucleophilic properties of the 3 -OH during DNA religation
(28). In the structure with MTS2–11 in the absence of divalent ions (Figure 3A), E24 of MtbTOP1 is well positioned
to donate a proton to the 3 -OH leaving group. Partly due
to the placement of this strictly conserved glutamate, the
MtbTOP1-704t/MTS2–11 structure is seen as the probable structure prior to the DNA cleavage step. In the structure with MTS2-13 in the presence of Mg2+ (Figure 3B),
E24 is critical in forming and positioning the binding site
for Mg2+ , which can then increase the nucleophilicity of the
3 -OH during DNA religation. The position of E24 in the
MtbTOP1-704t/MTS2-13/Mg structure also supports the
assignment of this structure as the likely structure following
DNA religation.
The critical functions of the strictly conserved glutamate
E24 may be assisted by charge relay involving D111 and
H389, with water molecules in the hydrogen-bonding network at the active site being potential participants in acidbase catalysis. D111 and H365 in EcTOP1 are well positioned for the proposed charge relay (42,50). The sequence
of charge relay during DNA cleavage would involve donation of a proton from the positively charged invariant histidine to the nearby aspartate, which then relays the charge to
the strictly conserved glutamate so that it can be protonated
at physiological pH to act as a general acid for neutralizing
the negative charge on the 3 -hydroxyl leaving group. The
bell-shaped pH dependence of EcTOP1 catalysis is modified by H365 mutations (42), consistent with the role of this
conserved histidine in optimal catalysis at physiological pH
(42). A nearby water molecule can potentially replace the
role of the histidine for donating a proton if the histidine is
mutated to another residue. However, the role of EcTOP1
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Figure 5. Mapping of exact cleavage site on single-stranded oligonucleotide substrates. (A) Cleavage and religation of MTS2–11 substrate by MtbTOP1704t. Lane 1: MTS2–11 substrate with no enzyme added. Lane 2: MTS2-7 oligo standard. Lane 3: MTS2-6 oligo standard. Lane 4: cleavage by 1 pmol
MtbTOP1-704t. Lane 5: cleavage by 1pmol MtbTOP1-704t with 0.5 mM Mg2+ added for DNA religation. Lane 6: cleavage by 1pmol MtbTOP1-704t
followed by addition of 0.5 mM Mg2+ and 1 M NaCl to dissociate the enzyme following DNA religation. (B) Cleavage of MTS2-13 by MtbTOP1-704t and
MsmTOP1-701t. Lane 1: MTS2-13 substrate with no enzyme added. Lanes 2, 3: 1 and 2 pmol of MtbTOP1-704t added. Lanes 4: MTS2-6 oligo standard.
Lane 5: MTS2-7 oligo standard. Lanes 6, 7: 1 and 2 pmol of MsmTOP1-701t added. (C) Cleavage product with STS32 oligonucleotide substrate. Lane 1:
STS32 substrate with no enzyme added. Lanes 2, 3 and 6: 1 pmol MtbTOP1-704t, MtbTOP1 and MsmTOP1 added respectively. Lanes 4: STS18 oligo
standard. Lane 5: STS19 oligo standard.

glutamate E9 as a general acid during DNA cleavage is inconsistent with the reported retention of DNA cleavage activity for the EcTOP1 E9Q mutant (49).
In order to clarify the catalytic role of this critical conserved glutamic acid residue, we mutated E24 of MtbTOP1
to alanine or glutamine. Both the MtbTOP1-E24A and
MtbTOP1-E24Q mutants had null relaxation activity as
well as no observable DNA cleavage activity (Figure 6A
and B). Similar results were obtained for the MsmTOP1
E21A and E21Q mutants (Figure 6C and D). Gel shift assays of non-covalent binding to the oligonucleotide substrate showed that the binding of the MtbTOP1-E24A and
MtbTOP1-E24Q mutant proteins remain unaffected prior
to the DNA cleavage step (Figure 6E). To confirm that the
conserved glutamate in EcTOP1 functions in the same capacity, we also showed that the EcTOP1-E9Q mutant protein had no relaxation activity and no detectable cleavage
activity when tested with substrate ssDNA under our experimental conditions (Supplementary Figure S2). In the
report of the previous study of the EcTOP1-E9Q mutation,
it was stated that: ‘Further confirmation of the presence of
the intended mutation in each of the mutant plasmid was
carried out by DNA sequencing’ (49). If the EcTOP1 gene

for the mutant clone in this previous study has not been sequenced in entirety, it cannot be ruled out that there may be
other substitutions to account for the differences in cleavage
activity observed.
DISCUSSION
In a model of DNA cleavage proposed for type IIA topoisomerases (23), a divalent metal ion and a conserved arginine
interact with the scissile phosphate to stabilize the transition
state while a second metal ion interacts with the -1 phosphate to position the scissile phosphate in the active site for
cleavage by the tyrosine nucleophile (Figure 4C). Alternatively, a moving metal mechanism involving only one metal
ion has been proposed based on two S. aureus type IIA gyrase structures (44), in which a metal-binding site is in different positions at the active site, 2.8 Å apart between a precleavage structure (PDB 2XCS, Figure 4B) to a structure
with DNA cleaved (PDB 2XCT).
We have noticed that in the MtbTOP1-704t/MTS213/Mg structure there were additional smeared electron
densities between D111 and Y342 (not shown in figures).
Due to the limit of structural resolution, it is uncertain if
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Figure 6. Substitutions of invariant glutamate prevent relaxation of supercoiled DNA and ssDNA cleavage by mycobacterial topoisomerase I without
affecting non-covalent DNA binding. (A) Relaxation assay: Agarose gel electrophoresis of products from incubation of supercoiled DNA with wild-type
and E24A, E24Q mutant MtbTOP1 at 37◦ C for 30 min. (B) ssDNA cleavage assay: STS32 oligonucleotide labeled with 32 P at the 5 -end was incubated with
wild-type and mutant MtbTOP1. (C) Relaxation assay of wild-type and E21A, E21Q mutant MsmTOP1. (D) ssDNA cleavage of wild-type and mutant
MsmTOP1. (E) ssDNA binding assay of wild-type and mutant MtbTOP1: Electrophoretic mobility shift assay for formation of non-covalent complex
between labeled STS32 oligonucleotide and enzyme. The graph shows average and standard means from results of three experiments.

there is a second metal-binding site at the active site based
on this MtbTOP1-704t/MTS2-13/Mg structure. Because
of this uncertainty, we refrain from proposing a comprehensive catalytic mechanism for bacterial topoisomerase I that
specifies a single metal ion or two metal ions that would be
required for DNA religation. However, the active site features observed in the newly available structures, in combination with the functional data, do shed light on some catalytic steps that should apply to all bacterial topoisomerase
I enzymes due to the very high degree of conservation of
the active site residues and structures within this group. For
metal-independent DNA cleavage (proposed scheme shown
in Figure 7), a water molecule in the vicinity of the active site
tyrosine Y342 may act as a general base to extract a proton
from the Y342 hydroxyl side chain, initiating nucleophilic
attack. The strictly conserved arginine (R344 in MtbTOP1)
then interacts with both the deprotonated tyrosine hydroxyl
oxygen and the scissile phosphate to stabilize the negative charge of the phosphorane transition state. Secondly,
E24 could act as general acid to protonate the 3 -O leaving
group. D111 and H389 are in place for charge relay to assist E24 (Figure 3A). This scheme proposed for DNA cleavage is supported by the previously observed requirement of
Mg2+ for DNA cleavage by EcTOP1 mutants where the conserved arginine (R321) is altered to an aromatic residue that
can interact with the active site tyrosine through hydrophobic interaction, but cannot provide any electrostatic inter-

action (51). Additionally, the stacking interaction between
the invariant histidine (H389 in MtbTOP1) and the catalytic
tyrosine may also help to stabilize the DNA cleavage transition state in the absence of Mg2+ . While we cannot rule out
additional conformational change has to take place following the formation of the holo structure shown in Figure 3A
prior to DNA cleavage taking place, it is possible that the
water molecule needed as general base is not in the prerequisite position in this holo structure to extract the proton
from the active site tyrosine side chain in order to initiate
DNA cleavage. This may explain why DNA cleavage does
not take place in the crystal. It is also noted that while D111
and D113 side chains in the structure seen here are less ordered, the N111 and D113 side chains in the covalent complex of EcTOP1 are both ordered. The precise positioning
of these residues may be needed for DNA cleavage to take
place.
Because type IA topoisomerases break and rejoin a
single-strand of DNA that is not base-paired to its complementary strand, Watson-Crick base pairing is not available to help align the 3 -OH and 5 -phoshoryl group linked
to the tyrosine in the covalent intermediate for rejoining.
Therefore, we believe that in the metal-dependent ligation,
metal ion(s) may be required for these DNA ends to be
joined by a phosphodiester linkage in the DNA religation
step. In Figure 3B, the observed Mg2+ ion can help activate
the 3 -hydroxyl group as a nucleophile while E24, D111 and
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Figure 7. Proposed scheme for DNA cleavage in the absence of divalent
ions. The scheme is based on the structure of the MtbTOP1-704t/ssDNA
complex (PDB 6CQI). The active site tyrosine Y342 hydroxyl group is positioned for attack of the scissile phosphate through the network of noncovalent interactions extending from the vicinity of Y342 to Y176 shown
in Figures 1 and 2. A water nearby that is invisible in the PDB structure
is required to act as general base (B:) to activate the hydroxyl nucleophile.
The positive charge of the Arg344 side chain plays a critical role in stabilizing the negative charge on the hydroxyl nucleophile and the transition
state. The E24 side chain interacts directly as general acid with the DNA
3 -hydroxyl leaving group to provide a proton that can be extracted from
the positively charged H389 side chain via proton relay through the D111
side chain.

D113 help to position the metal ion and consequently the
3 -hydroxyl group at a required distance from the phosphotyrosine linkage. Based on this study, it is not clear if there
is a second Mg2+ ion present during religation, which could
be responsible for positioning the 5 -phosphoryl tyrosine
and stabilization of the transition state for DNA rejoining.
One possible scenario is that there is such a second metalbinding site, which dissociates after DNA rejoining is done.
This scenario might explain why the second metal-binding
site is not readily observed. It is worthwhile to emphasize
that the positive charge of the conserved arginine (R344 in
MtbTOP1) interacting with the active site tyrosine leaving
group is essential for DNA rejoining. DNA cleavage intermediates accumulate in vivo when this arginine in EcTOP1
(R321) is mutated to a hydrophobic amino acid (51). The
presence of Mg2+ ions cannot compensate for the absence
of the arginine positive charge necessary for DNA rejoining. Therefore even though the second metal ion may be in
a position to stabilize the negative charge of the tyrosine
hydroxyl leaving group as expected for the canonical twometal ion mechanism, the positive charge of this arginine is
still required for interacting with the tyrosine hydroxyl negative charge during DNA rejoining.

We understand that the roles proposed for the divalent
ion described above differ from the classic two-metal ion
mechanism, in which both metal ions interact with the transition state, with one assisting in the activation of the nucleophile while the other stabilizes the leaving group (52).
There are also significant differences from the two-metal ion
mechanism proposed for type IIA topoisomerase (23), with
one metal ion assisting the acid-base catalysis by interacting with the transition state and the second metal ion interacting with an adjacent phosphate to anchor the substrate
DNA. Moreover, we also cannot disregard the ‘one moving metal’ mechanism (44). Particularly, this is because very
similar metal-binding sites have been observed in the crystal structures of both type IA and type IIA topoisomerases
(Figure 4).
The preferred DNA cleavage sites of MtbTOP1 have a cytosine base at the –4 position upstream of the scissile phosphate (31). This cleavage site preference holds true for all
bacterial topoisomerase I, but not for topoisomerase III.
We propose that the arginines (R194 and R547) and the Nterminus of the ␣3 helix of D4 interact with the phosphate
backbone (Figure 2B), while the arginines (R168 and R172)
interact with the cytosine base in the -4 position (Figure
2B), and the side chain of Y176 inserts between two bases
(Figure 2B). Together, these interactions position the DNA
substrate and ensure that the catalytic tyrosine hydroxyl is
at the required distance from the scissile phosphate in the
active site for DNA cleavage to take place. Concurrently,
the interactions of R168 and R172 with the cytosine base
in the –4 position contribute to the preference or specificity
of DNA cleavage sites. Analysis of the site-directed alanine
substitution mutations of the EcTOP1 residues required for
the interactions with the cytosine in the –4 position showed
that these mutants have significantly decreased DNA cleavage activity, and that the preference of the cytosine in the –4
position can be altered to an adenine base instead (38).
A lysine conserved in topoisomerase III enzymes (K8 in
EcTOP3) has been proposed to replace the role of the metallic cation required by type IIA topoisomerase in the active
site (23). A lysine is conserved in bacterial topoisomerase I
in a nearby, but non-equivalent position (K13 in EcTOP1,
K28 in MtbTOP1) as shown in Supplementary Figure S1.
Site-directed mutagenesis of EcTOP1 K13 showed that this
lysine is required for DNA cleavage (39), but its positively
charged side chain is not in the vicinity of the scissile phosphate in any EcoTOP1 crystal structures available to date.
We also find that K28 is not near the DNA phosphates in
the active site of MtbTOP1-704t bound to DNA in the absence or presence of metal ions (Figure 3). We cannot dismiss the possibility that K28 of MtbTOP1 and its equivalent lysine in bacterial topoisomerase I can move into the
active site to interact with the transition state in a reaction
intermediate that has not been captured by crystallography.
It is also possible that the role of K13 in EcTOP1 and K28
in MtbTOP1 in catalysis is different from K8 in EcTOP3,
as their positions are not equivalent (Supplementary Figure
S1). The lysine conserved in this specific position of bacterial topoisomerase I may be required for the assembly of the
active site. It may also have a polarizing effect on the nearby
acidic residues, as previously proposed (39).
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Certain mutants of EcTOP1 and MsmTOP1 with specific
substitutions at the conserved arginine and aspartates in the
active site have been demonstrated to be dominant lethal
(53). These mutant enzymes can still cleave DNA while
DNA rejoining in the presence of Mg2+ became less efficient, resulting in accumulation of covalent intermediates
and bacterial cell death (47,51,53). MtbTOP1 is essential for
the viability of the TB pathogen, and can be exploited as a
novel target for discovery of new therapies (1,2,54,55) in the
treatment of MDR-TB. Genetic manipulation to deplete
MtbTOP1 and inhibition of MtbTOP1 activity by small
molecules have been shown to inhibit growth (2,54). Significant bactericidal activity may require only a small number
of the trapped covalent topoisomerase-DNA intermediates
(56) through the action of topoisomerase poison inhibitors
(11,12). Small molecules that can selectively perturb the
MtbTOP1 active site interactions in the presence of Mg2+
observed in the structure of enzyme/DNA/Mg complex reported here may be candidates for topoisomerase poison inhibitors against MtbTOP1.
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